Scope of the Report:
Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.
The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.
Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.
North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.
North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.
Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new Globalmarketers.biz Research study.
This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
To Understand How Covid-19 Impact on this industry. Get Free Sample Report:
Global Testosterone Replacement Therapy report portrays the fundamental details of the dominant market players elaborating their business profiles, Testosterone Replacement Therapy market revenue, sales volume, press releases, technical developments taking place in this industry.
Report is segmented into different parts as below:
Global Testosterone Replacement Therapy Market Details Based On Key Players:
AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals
Global Testosterone Replacement Therapy Market Details Based on Product Category:
GelsInjectionsPatchesOther
Global Testosterone Replacement Therapy Market Details Based On Key Product Applications:
HospitalsClinicsOthers
Global Testosterone Replacement Therapy Market Details Based On Regions
Inquire Before Buying Or Ask For Custom Requirement:
The first part of the report portrays the information related to the basic Testosterone Replacement Therapy introduction, key market players, their company profiles, sales ratio, demand and supply volume, Testosterone Replacement Therapy market gains during 2018 and 2019. The second part of the Testosterone Replacement Therapy report extracts more details stating the sales revenue of each Testosterone Replacement Therapy industry player, the business strategies followed by them. The third part of the report displays the competitive scenario of all the Testosterone Replacement Therapy market players on basis of the revenue gains.
The fourth part of the report enlists the Testosterone Replacement Therapy details based on key producing regions and Testosterone Replacement Therapy market gains during the period from 2015 to 2019. Fifth, sixth, seventh, eighth and ninth part of the Testosterone Replacement Therapy report enlists the major countries within the regions and the Testosterone Replacement Therapy revenue generated during the period from 2012 to 2017. Tenth and eleventh part of the Testosterone Replacement Therapy report mentions the variety of Testosterone Replacement Therapy product applications, Testosterone Replacement Therapy statistics during 2015 to 2019.
Part number twelve, thirteen, fourteen and fifteen provides information regarding the futuristic Testosterone Replacement Therapy market trends expected during the forecast period from 2020 to 2024, Testosterone Replacement Therapy marketing strategies, Testosterone Replacement Therapy market vendors, facts and figures of the Testosterone Replacement Therapy market and vital Testosterone Replacement Therapy business conclusion along with data collection sources and appendix.
What Testosterone Replacement Therapy Market Report Contributes?
View Full Table Of Content: @
Contact Us:
Name: Alex White
Phone: US: +1(806)4400782/ UK: +44 33 3303 4979
Email: [emailprotected]
Continue reading here:
Global Testosterone Replacement Therapy Market 2020 Industry by Type, by Application, by Share, by Revenue and by Region Forecast to 2024 -...
